# The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer

> **NCT03768479** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 68 (estimated)

## Conditions studied

- Estrogen Receptor-positive Breast Cancer
- Fulvestrant

## Interventions

- **DEVICE:** 18F-FES-PET

## Key facts

- **NCT ID:** NCT03768479
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-05
- **Primary completion:** 2018-12
- **Final completion:** 2019-03
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03768479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03768479, "The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03768479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*